Aqueous Extraction

Aqueous extraction is commonly utilized for water-soluble phycobiliproteins like phycocyanin and phycoerythrin. In this method, the cyanobacterial biomass is suspended in a phosphate buffer and subjected to centrifugation to separate the soluble proteins from cell debris. This method ensures high purity and stability of the extracted compounds, which are essential for their biological activities (Sabat et al., 2025).

Organic Solvent Extraction

Organic solvent extraction is effective for isolating lipophilic compounds, including carotenoids and fatty acids. Solvents such as acetone, ethanol, and methanol are employed to dissolve the target compounds, which are then separated from the biomass through centrifugation. The choice of solvent significantly impacts the yield and quality of the extracted compounds, making optimization of this method crucial for effective extraction (Sabat et al., 2025).

Enzymatic Extraction

Enzymatic extraction utilizes specific enzymes to disrupt cell walls and release intracellular compounds. This method is advantageous as it minimizes the use of harsh chemicals, leading to cleaner extracts with preserved bioactivity. Enzymes such as cellulases and proteases are commonly used, allowing for selective extraction of peptides and other bioactive molecules (Sabat et al., 2025).

Anticancer Properties of Cyanobacterial Metabolites

Cyanobacterial metabolites have shown promising anticancer properties, making them potential candidates for drug development. The mechanisms underlying their anticancer effects are diverse and include apoptosis induction, cell cycle arrest, and modulation of oxidative stress.

Mechanisms of Action

1. Induction of Apoptosis
   Cyanobacterial compounds can trigger apoptosis, a programmed cell death mechanism essential for eliminating cancer cells. For example, cryptophycins, derived from Nostoc species, have been shown to bind to specific proteins linked to cancer, promoting cell death while sparing normal cells (Sabat et al., 2025).

2. Cell Cycle Arrest
   Many cyanobacterial metabolites can interrupt the cell cycle of cancer cells, halting uncontrolled proliferation. For instance, compounds like calothrixin A induce G1 and G2/M phase arrest, thereby preventing further growth of cancer cells (Sabat et al., 2025).

3. Modulation of Oxidative Stress
   Cyanobacterial antioxidants, such as carotenoids and phycocyanin, can scavenge free radicals, reducing oxidative stress and promoting cellular health. This dual action allows for selective targeting of cancer cells, increasing their susceptibility to treatment while protecting normal cells (Sabat et al., 2025).

Synergistic Effects with Conventional Treatments

Cyanobacterial phycocompounds have demonstrated synergistic interactions with traditional anticancer therapies. For instance, the combination of phycocyanin with doxorubicin enhances the cytotoxic effects of the chemotherapeutic agent while reducing its side effects. This synergy is crucial in overcoming drug resistance, a common challenge in cancer treatment (Sabat et al., 2025).

Antimicrobial Effects of Cyanobacterial Derivatives

With the rise of antibiotic-resistant bacteria, the need for novel antimicrobial agents has never been more pressing. Cyanobacteria produce a range of bioactive metabolites that exhibit antimicrobial properties against various pathogens.

Mechanisms of Antimicrobial Action

1. Inhibition of Quorum Sensing
   Many cyanobacterial compounds can disrupt quorum sensing, a communication mechanism used by bacteria to coordinate their behavior. This inhibition can prevent biofilm formation and reduce virulence, making bacteria more susceptible to treatment (Sabat et al., 2025).

2. Disruption of Cell Wall Synthesis
   Certain cyanobacterial metabolites, such as tolyporphine K, inhibit the synthesis of bacterial cell walls, leading to cell lysis and death. This mechanism is particularly effective against Gram-positive bacteria like Staphylococcus aureus (Sabat et al., 2025).

3. Targeting Essential Bacterial Processes
   Cyanobacterial extracts have been shown to interfere with essential bacterial functions, such as protein synthesis and cellular metabolism, ultimately leading to bacterial cell death. This broad-spectrum activity is beneficial in combating multi-drug resistant strains (Sabat et al., 2025).

Synergistic Interactions with Conventional Treatments

The combination of cyanobacterial phycocompounds with conventional antibiotics has shown significant promise in enhancing antimicrobial efficacy. Studies have indicated that when combined with antibiotics, these compounds can reduce the required doses and mitigate the development of drug resistance.

Examples of Synergistic Interactions

1. Cyanobacterial Extracts and β-lactam Antibiotics
   Extracts from cyanobacteria have been found to restore the activity of β-lactam antibiotics against resistant strains of bacteria, offering a potential strategy for overcoming antibiotic resistance (Sabat et al., 2025).

2. Antimicrobial Peptides and Conventional Antibiotics
   The use of cyanobacterial-derived antimicrobial peptides in conjunction with standard antibiotics has demonstrated enhanced antibacterial activity, particularly against resistant pathogens like MRSA (Sabat et al., 2025).

Future Directions in Cyanobacterial Research and Applications

The therapeutic potential of cyanobacterial phycocompounds is vast, and ongoing research is crucial to unlocking their full capabilities. Future studies should focus on several key areas:

1. Optimizing Extraction Techniques
   Continued advancements in extraction methods will enhance the yield and purity of bioactive compounds, ensuring their effectiveness in therapeutic applications.

2. Clinical Trials and Safety Assessments
   Rigorous clinical trials are necessary to evaluate the safety and efficacy of cyanobacterial-derived compounds in humans, paving the way for their incorporation into standard treatment regimens.

3. Investigating Combined Therapies
   Further exploration of the synergistic effects between cyanobacterial compounds and existing therapies will provide insights into novel treatment strategies that enhance therapeutic outcomes.

4. Understanding Mechanisms of Action
   A deeper understanding of the molecular mechanisms by which cyanobacterial metabolites exert their effects will be essential for developing targeted therapies in both cancer and infectious diseases.

5. Sustainable Cultivation Practices
   As the demand for cyanobacterial products increases, sustainable cultivation and extraction practices will be crucial to ensure environmental conservation and economic viability.

FAQ Section

What are cyanobacterial phycocompounds?
Cyanobacterial phycocompounds are bioactive molecules produced by cyanobacteria, including peptides, alkaloids, and pigments, known for their therapeutic properties against cancer and microbial infections.

How are these compounds extracted?
Extraction methods vary based on the properties of the target compounds and include aqueous extraction, organic solvent extraction, and enzymatic extraction.

What are the anticancer properties of cyanobacterial metabolites?
Cyanobacterial metabolites can induce apoptosis, disrupt cell cycle progression, and modulate oxidative stress, exhibiting significant anticancer activity.

Can cyanobacterial compounds enhance the efficacy of antibiotics?
Yes, studies have shown that cyanobacterial compounds can synergistically enhance the effectiveness of conventional antibiotics, particularly against drug-resistant pathogens.

What are the future directions for cyanobacterial research?
Future research will focus on optimizing extraction techniques, conducting clinical trials, exploring combined therapies, understanding mechanisms of action, and implementing sustainable cultivation practices.

References

1. Sabat, S., Patra, S., Swain, S., Bej, S., Bishoyi, A. K., Sahoo, C. R., & Padhy, R. N. (2025). Phycocompounds from Cyanobacteria: Exploring Synergistic Effects with Conventional Anticancer and Antimicrobial Properties. ACS Omega. Retrieved from https://pubmed.ncbi.nlm.nih.gov/12177642/

2. Vázquez-Morales, L., Aguirre, G., Molina-Jiménez, T., Zepeda, R. C., López-Franco, Ó., Flores-Muñoz, M., Juárez-Portilla, C. (2025). Ovarian Hormones and Addictive Behaviour Vulnerability: Insights From Preclinical Studies. Addiction Biology. Retrieved from https://pubmed.ncbi.nlm.nih.gov/12145796/

3. Mirza, S. A., Mohammed, N. S., & Ali, Z. Q. (2025). The effects of methamphetamine intoxication on acute kidney injury in Iraqi male addicts. Toxicology Reports. Retrieved from https://doi.org/10.1016/j.toxrep.2025.102065

4. Zhang, C., Zhang, R., Zhao, G., Wu, Z., Song, W., Ran, R., Zhou, K., & Zhang, H. (2025). Chronotherapy and intervertebral disc degeneration: understanding the role of circadian rhythm in degenerative processes. Frontiers in Cell and Developmental Biology. Retrieved from https://doi.org/10.3389/fcell.2025.1586193

5. Lin, L., & Alvarez-Puebla, R. (2025). Surface-Enhanced Raman Spectroscopy for Biomedical Applications: Recent Advances and Future Challenges. ACS Applied Materials & Interfaces. Retrieved from https://pubmed.ncbi.nlm.nih.gov/12184206/